Botox
Get
a free case evaluation<<<<<<<
FDA Notifies Public of Adverse Reactions Linked
to Botox Use
Ongoing safety review of Botox, Botox Cosmetic and Myobloc taking
place.
The U.S. Food and Drug Administration (FDA) recently announced
that it would undertake a safety review of Botox, Botox Cosemtic
and Myobloc. The announcement came after the FDA received reports
of serious adverse reaction, including respiratory failure and
even death. If you or a loved one has suffered as a result of
using one of these products, please CLICK
HERE for a free consultation.
- Botox
(botulinum type A) is approved by the FDA for treatment of
conditions such as blepharospasm (spasms of the eyelids) and
cervical dystonia (severe neck muscle spasms).
- Botox Cosmetic
also, botulinum type A is approved for temporary
improvement in the appearance of moderate to severe facial
frown lines.
- Myobloc or botulinum type B is approved for treatment of
adults with cervical dystonia.
According to FDA the adverse reactions
involved Botox injections for FDA approved and non-approved or “off
label” usages.
Off-label uses, though not prohibited or necessarily inappropriate,
are not FDA approved. Some of the most serious injuries occurred
in children treated for limb spasticity associated with cerebral
palsy. Treatment of spasticity is not an FDA approved use of
Botulism toxins in adults or children.
The adverse events appear to be related to the spread of the
toxin to areas in the body beyond the injection site and mimic
symptoms of botulism, which may include difficulty swallowing,
weakness and breathing problems.
The agency is not advising health care professionals to discontinue
prescribing these products at this time. It will continue its
review of safety data from clinical studies submitted by the
drug’s manufacturer, post marketing adverse events reports
and medical literature before issuing any public notice regarding
it’s conclusions, recommendations and any regulatory actions. If you or a loved one suffered a serious injury or death as
a possible result of using Botox or Myobloc, you may want to
contact a Botox attorney or a Myobloc attorney. A lawyer familiar
with new developments in the investigation of these products
may be able to help you make important personal and legal decisions.
Please CLICK HERE for a free consultation.
CLICK HERE for the FDA News Release from 2/8/2008
http://www.fda.gov/cder/drug/early_comm/botulinium_toxins.htm
You can call us at 1-800-992-6878 or CLICK HERE to inquire by
email.
|